CCN3 (NOV) Drives Degradative Changes in Aging Articular Cartilage by Kuwahara, Miho et al.
 International Journal of 
Molecular Sciences
Article
CCN3 (NOV) Drives Degradative Changes in Aging
Articular Cartilage
Miho Kuwahara 1,2, Koichi Kadoya 3, Sei Kondo 1, Shanqi Fu 1, Yoshiko Miyake 1, Ayako Ogo 1,
Mitsuaki Ono 4, Takayuki Furumatsu 5, Eiji Nakata 5, Takako Sasaki 6, Shogo Minagi 2,
Masaharu Takigawa 7, Satoshi Kubota 1 and Takako Hattori 1,*
1 Department of Biochemistry and Molecular Dentistry, Okayama University Graduate School of Medicine,
Dentistry and Pharmaceutical Sciences, Okayama 700-8525, Japan;
kuwahara.miho@s.okayama-u.ac.jp (M.K.); de421016@s.okayama-u.ac.jp (S.K.);
fushanqi@s.okayama-u.ac.jp (S.F.); yoshiko-m@okayama-u.ac.jp (Y.M.); carinablue2004@yahoo.co.jp (A.O.);
kubota1@md.okayama-u.ac.jp (S.K.)
2 Department of Occlusal and Oral Functional Rehabilitation, Okayama University Graduate School of
Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8525, Japan; minagi@md.okayama-u.ac.jp
3 Department of Oral and Maxillofacial Surgery, Okayama University Graduate School of Medicine,
Dentistry and Pharmaceutical Sciences, Okayama 700-8525, Japan; de422015@s.okayama-u.ac.jp
4 Department of Molecular Biology and Biochemistry, Okayama University Graduate School of Medicine,
Dentistry and Pharmaceutical Sciences, Okayama 700-8525, Japan; mitsuaki@md.okayama-u.ac.jp
5 Department of Orthopedic Surgery, Okayama University Graduate School of Medicine,
Dentistry and Pharmaceutical Sciences, Okayama 700-8525, Japan; matino@md.okayama-u.ac.jp (T.F.);
eijinakata8522@yahoo.co.jp (E.N.)
6 Department of Biochemistry, Faculty of Medicine, Oita University, Oita 879-5593, Japan; tsasaki@oita-u.ac.jp
7 Advanced Research Center for Oral and Craniofacial Sciences, Okayama University Dental School/Graduate
School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8525, Japan;
takigawa@md.okayama-u.ac.jp
* Correspondence: hattorit@md.okayama-u.ac.jp; Tel./Fax: +81-862-356-646
Received: 4 September 2020; Accepted: 8 October 2020; Published: 13 October 2020


Abstract: Aging is a major risk factor of osteoarthritis, which is characterized by the degeneration of
articular cartilage. CCN3, a member of the CCN family, is expressed in cartilage and has various
physiological functions during chondrocyte development, differentiation, and regeneration. Here, we
examine the role of CCN3 in cartilage maintenance. During aging, the expression of Ccn3 mRNA in
mouse primary chondrocytes from knee cartilage increased and showed a positive correlation with
p21 and p53 mRNA. Increased accumulation of CCN3 protein was confirmed. To analyze the effects
of CCN3 in vitro, either primary cultured human articular chondrocytes or rat chondrosarcoma cell
line (RCS) were used. Artificial senescence induced by H2O2 caused a dose-dependent increase in
Ccn3 gene and CCN3 protein expression, along with enhanced expression of p21 and p53 mRNA and
proteins, as well as SA-β gal activity. Overexpression of CCN3 also enhanced p21 promoter activity via
p53. Accordingly, the addition of recombinant CCN3 protein to the culture increased the expression
of p21 and p53 mRNAs. We have produced cartilage-specific CCN3-overexpressing transgenic mice,
and found degradative changes in knee joints within two months. Inflammatory gene expression was
found even in the rib chondrocytes of three-month-old transgenic mice. Similar results were observed
in human knee articular chondrocytes from patients at both mRNA and protein levels. These results
indicate that CCN3 is a new senescence marker of chondrocytes, and the overexpression of CCN3
in cartilage may in part promote chondrocyte senescence, leading to the degeneration of articular
cartilage through the induction of p53 and p21.
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1. Introduction
Aging is a main risk factor of senescence, which involves a decrease in biological functions such
as muscle strength, nerve conduction velocity, vital capacity, and resistance to illness. In terms of
cartilage, aging increases the risk of osteoarthritis (OA), which is the most common joint disease
characterized by articular cartilage degeneration, and causes severe joint pain, physical disability, and
impairment of quality of life. Despite recent advances in our knowledge of disease pathogenesis,
treatment is still a challenge and, unlike for inflammatory joint diseases, no disease-modifying drugs
are currently available for OA [1]. Although OA is not an inevitable consequence of senescence,
aging is a strong risk factor for OA [2]. Chondrocytes undergo age-dependent senescence, which is
characterized by a decline in the proliferative and synthetic capacity of cellular products, including
their extracellular matrices; this is considered to play a significant role in the pathology of OA [3].
Although aging and OA are closely linked, they are independent processes. Several reports show
the mechanism of contribution of aging to OA: age-related inflammation [4], cellular senescence
(including the senescence-associated secretory phenotype (SASP)) [5–7], mitochondrial dysfunction
and oxidative stress [8–10], and dysfunction in energy metabolism. This metabolic dysfunction is
due to the reduced activity of 5′-AMP-activated protein kinase (AMPK) [11–13], which is associated
with reduced autophagy. Alterations in cell signaling due to age-related changes in the extracellular
matrix [14] are also of note. Improved understanding of the aging-related mechanisms that promote
OA could lead to the discovery of new targets for therapies that aim to slow or stop the progression of
this chronic and disabling disease.
Cellular communication network factor 3 (CCN3), previously called nephroblastoma
overexpressed (NOV), is a secreted multifunctional protein involved in a variety of cellular processes,
and interacts with various extracellular and transmembrane proteins [15–17]. Our previous studies
have shown that CCN3 suppresses the proliferation and maturation of growth plate chondrocytes,
regulating the expression of chondrocytic extracellular matrix (ECM) genes and Sox9 [18]. In the present
study, we show for the first time that the expression of CCN3 is elevated in aging mouse and human
articular cartilage. Cell cycle arrest by H2O2 demonstrated induction of Ccn3 as well as Col10a1 and
matrix metalloproteinases mRNA, and downregulation of Col2a1 mRNA. The overexpression of CCN3
induced promoter activity of p21, which has multiple p53-responsive elements. An in vivo mouse model
of CCN3 overexpression in cartilage showed prominent degenerative changes in articular cartilage.
Here, we propose that CCN3 is a novel senescence marker of chondrocytes, and overexpression
of CCN3 in cartilage can be one of the factors that partly promotes chondrocyte senescence and
degeneration of articular cartilage via p53 and p21.
2. Results
2.1. Increased Expression and Accumulation of CCN3 in Mouse Articular Cartilage with Aging
First, we examined the expression level of Ccn3 mRNA in primary mouse chondrocytes from
embryonic 18.5-day rib cage cartilage and postnatal two days to 37-weeks-old knee joints by quantitative
RT–PCR standardized by either glyceraldehyde 3-phosphate dehydrogenase (Gapdh) mRNA, total
RNA amount, or transmembrane protein 199 (Tmem199) mRNA. Since for Gapdh, a housekeeping
gene, mRNA expression decreased with age (Supplemental Figure S1a), Tmem199, a gene reported to
undergo little fluctuation in gene expression during aging [19], was also used for the normalization of
Ccn3 mRNA (Supplemental Figure S1b). A strong positive correlation was observed between age and
Ccn3 expression level, standardized by either Gapdh mRNA, total RNA amount, or Tmem199 mRNA
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(Spearman’s rank correlation coefficient (rs): 0.77 for Ccn3/Gapdh, 0.77 for Ccn3/Tmem199, and 0.97 for
Ccn3/µg RNA; p < 0.01, Figure 1A–C). Although both Gapdh and Tmem199 mRNA expression showed
negative correlation with age, altogether these results indicated a strong positive correlation of CCN3
expression with age in chondrocytes. For better comparison, expression of all other genes was hence
standardized to Gapdh.
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Figure 1. Comparison of mRNA expression levels of (A–C) Ccn3, (D) p16, (E) p53, (F) p21, (G) Acan,
(H) Col2a1, (I,J) Sox9, (K) Il-6, and (L) Il-8 in articular chondrocytes of different ages (embryo E18.5
represents RNA from ribcage chondrocytes of embryonic day 18.5). The expression level of Ccn3
mRNA was standardized with (A) Gapdh, (B) Tmem199, a gene with little fluctuation in expression
during aging, and (C) RNA amount. The expression level of Acan mRNA dramatically decreased
with age, but Col2a1 mRNA expression did not. Sox9 mRNA expression increased when it was
standardized by Gapdh; however, the expression level/µg RNA decreased with age. (K,L) Il-6 and
Il-8, as senescence-associated secretory phenotype (SASP) factors, also showed increased expression
with age (p < 0.05). Either rib cage (E.18.5) or knee articular (postnatal) cartilage was pooled from 8
embryos or 4 postnatal animals and seeded into at least 3 dishes. RNA from each dish was analyzed
with triplicate by real time PCR, and the average of the value from one RNA sample was plotted
as one ‘dot’. (M–P) Immunohistochemical staining of CCN3 in one-, two-, and seven-month old
mouse articular cartilage. CCN3-positive chondrocytes (arrow) increased in the superficial layer of
articular cartilage (dotted circle) of seven-month-old compared with one-month-old mice. No signal
was observed without CCN3-specific antibody (Figure 1P, -1st Ab). Scale bar: 200 µm.
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To determine whether murine chondrocytes display characteristic features of senescent cells with
age, we assessed the expression of genes that arrest cell cycle, such as p16, p53, and p21. As shown in
Figure 1D–F, the expression of these genes was positively correlated with age (rs: 0.77 for p16/Gapdh,
0.77 for p53/Gapdh, and 0.82 for p21/Gapdh; p < 0.01).
Expression levels of chondrocyte marker genes were also assessed: Aggrecan and type 2 collagen
are the major and cartilage-specific components of the extracellular matrix. Postnatal expression of
Aggrecan (Acan) mRNA dropped dramatically (rs: −0.73 for Acan/Gapdh, p < 0.01), while no significant
age-related changes in Col2a1 expression were observed (Figure 1G,H) in this period. The expression
of Sox9, a transcription factor for cartilage differentiation, standardized by Gapdh mRNA increased
with age (rs: 0.69 for Sox9/Gapdh, p < 0.01), but decreased when standardized to RNA (rs: −0.88 for
Sox9/µg RNA, p < 0.01, Figure 1I,J; see discussion). Senescence-associated secretory phenotype (SASP)
-related inflammatory factors such as Il-6 or Il-8 were elevated with age (rs: 0.5670076 for Il-6/Gapdh,
and 0.5182002 for Il-8/Gapdh; p < 0.05, Figure 1K,L). Accumulation of CCN3 protein was observed by
immunohistochemical staining of CCN3 in knee joint cartilage from one-, two-, and seven-month-old
mice. The number of CCN3-positive chondrocytes increased in the superficial zone of seven-month-old
articular cartilage (Figure 1M–O). No positive staining was observed without CCN3-specific antibody
(Figure 1P).
2.2. Increased Expression of CCN3 in H2O2-Treated Chondrocytes
To induce cellular senescence by oxidative stress in vitro, human primary articular chondrocytes
from 48 years old patient (Figure 2A) and rat chondrosarcoma-derived cells (RCS, Figure 2B) were
exposed to H2O2 at various concentrations for 2 h, and the medium was changed to a normal
growing medium, followed by 24 h incubation. Thereafter, total RNA was extracted and subjected to
RT-qPCR analysis.
In human primary chondrocytes, CCN3 mRNA expression increased significantly by H2O2-
treatment in a dose-dependent manner (Figure 2A, * p < 0.05). The expression of p21 and p53 mRNAs
was also significantly induced by H2O2 in a dose-dependent manner (Figure 2A, * p < 0.05), indicating
cell cycle was arrested in H2O2-treated articular chondrocytes. Col2a1 mRNA was increased at
relatively lower concentration of H2O2 but increased concentration of H2O2 repressed the expression,
indicating that an escaping system exists from oxidative stress. Acan mRNA was reduced dose
dependently. Expression of COL10A1 and MMP13 by H2O2 was slightly induced, but it was not
significant (Figure 2A).
Similarly, in RCS cells, elevated expression of Ccn3, p21, and p53 mRNA was observed. Col2a1
and Acan mRNA were also reduced in a relatively higher concentration of H2O2, however, rather
lower concentration of H2O2 increased the expression in RCS cells. Mmp13 and Adamts5 encoding
matrix metalloproteinases, which specifically degrade cartilaginous matrices, and Col10a1, a marker of
hypertrophic cartilage, which is induced during osteophyte formation, were significantly induced by
treatment with H2O2 in RCS cells (Figure 2B, * p < 0.05), however, at highest concentration of H2O2,
Mmp13 mRNA was reduced, indicating that the maximum concentration of H2O2 to induce Mmp13
was lower than that for Col10A1 or Adamts5 mRNA in RCS cells.
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Figure 2. Increased expression of Ccn3 mRNA and protein in H2O2-treated chondrocytes. (A) Human 
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p21, p53, Col2a1, Acan, Col10a1, Mmp13, and Adamts5 mRNA levels were monitored and standardized 
with Gapdh. The data represent the mean ± SD (n = 3 individual cultures); * p ≤ 0.05. (C) Cell lysates 
were collected both 24 and 48 h after changing media and CCN3 protein level was monitored with an 
anti-CCN3 antibody. (D, left) Cell lysates were collected 48 h after changing media and p53 protein 
level was monitored with an anti-p53 antibody. (D, right) Band intensity of p53 was standardized to 
βactin. (E) Colorimetric detection of senescence associated β galactosidase in H2O2-treated RCS cells. 
RCS cells were treated with H2O2 at indicated concentration for 2 h and after media change further 
incubated for 36 h. bar: 200 µm. 
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p21, p53, Col2a1, Acan, Col10a1, p13, and Adamts5 mRNA levels were monitored and standardized
ith apdh. The data represent the ean ± S (n = 3 individual cultures); * p ≤ 0.05. (C) Cell lysates
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CCN3 and p53 production in H2O2-treated RCS cells was also monitored by Western blot using an
anti-CCN3 or anti-p53 antibody. CCN3 was accumulated in H2O2-treated RCS after 24 h incubation in
a dose-dependent manner, but 48 h after the H2O2 treatment at the highest concentration, the amount
of CCN3 as well as beta-actin decreased (Figure 2C). In contrast, p53 was accumulated in H2O2-treated
RCS after 48 h incubation in a dose-dependent manner (Figure 2D), but not after 24 h incubation (data
not shown), indicating 53 protein was accumulate fter CCN3 protein was produc . Specificity
of antisera against CCN3 was monitored by expressing green fluorescent protein (GFP)-fused CCN3
protein with or without Flag epitope using expression vector and those molecular weights were
compared with Western b ot signals obtained using anti GFP a tibody (Figure 3A,B).
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Cellular senescence induced by H2O2 treatment in RCS cells was also estimated by monitoring 
senescence associated (SA) β-gal activity. Thirty-six hours treatment with 100 and 200 µM H2O2 
exhibited SA-β-gal positive senescent cells in RCS cells (Figure 2E). 
2.3. Overexpression of CCN3 Stimulates p21 Promoter in RCS Cells 
To understand whether elevated CCN3 expression is a result of aging, or whether elevated 
CCN3 expression induces aging, we monitored the activity of a p21 promoter with a plasmid 
construct harboring p53 binding sites after overexpression of CCN3 in RCS cells. CCN3 
overexpression in RCS cells was confirmed by Western blot with both anti GFP antibody and CCN3 
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Figure 3. Induction of p21 pro oter activity by overexpression of CCN3 in RCS cells. Detection
of GFP-C () and GFP-2Flag-CCN3 () overexpression with (A) an anti-GFP antibody, and
(B) anti-CCN3 antibody. Two days after transfection of pEGFP-CCN3 and pEGFP 2Flag-CCN3 vector
(2 clones eac ) lectroporation, proteins were ex racted from the cell and subject d to Western
blot analy is. For the p21 promoter assay in (C), we used pEGFP- CN3. (C) pEGFP-CCN3 vector,
pGL3-PG12S containing p21 promoter with 12×multiple p53-binding sites, and pGL3-Renilla vector
were transfected by electroporation, and two days after transfection, firefly luciferase activity was
monitored and standardized with Renilla luciferase activity (The data represent the mean ± SD (n = 3
individual cultures); * p < 0.05).
Cellular senescence induced by H2O2 treatment in RCS cells was also estimated by monitoring
senescence associated (SA) β-gal activity. Thirty-six hours treatment with 100 and 200 µM H2O2
exhibited SA-β-gal positive senescent cells in RCS cells (Figure 2E).
2.3. Overexpression of CCN3 Stimulates p21 Promoter in RCS Cells
To understand whether elevated CCN3 expression is a result of aging, or whether elevated CCN3
expression induces aging, we monitored the activity of a p21 promoter with a plasmid construct
harboring p53 binding sites after overexpression of CCN3 in RCS cells. CCN3 overexpression in RCS
cells was confirmed by Western blot with both nti GFP antibody and CCN3 ntibody (Figure 3A,B, :
GFP-CCN3 (67 kDa), : GFP-2xFlag- CN3 (69 kDa)). Ov rexpressio of GFP-tagged both CCN3 and
Flag-CCN3 was also m nitored with green fluorescent protein (data not shown). The p21 promoter
activity was monitored two days after transfection. Increased p21 promoter activity was observed by
cotransfection of the pEGFP-CCN3 vector in a dose-dependent manner (Figure 3C, *: p < 0.05). These
results suggested that overexpression of CCN3 in RCS cells induces p21 expression through induction
of p53.
2.4. Treatment with CCN3 Stimulates p21, p53 mRNA Expression in Mouse Primary Chondrocytes and
RCS Cells
To see whether exogenously added CCN3 has ability to induce cell cycle arrest or not, recombinant
(r) CCN3 was added to mouse primary articular chondrocytes from 2 W old knee joints and RCS cells.
After 24 h incubation, total RNA was harvested and analyzed.
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As a result, p21 was used to standardize total amounts of cDNA; in some experiments,
transmembrane protein 199 and p53 mRNA expression levels were significantly increased in both
mouse primary chondrocytes (Figure 4A) and RCS cells (Figure 4B) by the addition of rCCN3 (* p < 0.05,
** p < 0.01).
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Figure 4. Stimulation of p21 and p53 mRNA expression by recombinant CCN3 treatment in (A) mouse
primary articular chondrocytes from 2w knee joints and (B) RCS cells. Reco binant CCN3 was added
to the media at indicated concentrations (A) and 100 µg/ L (B). Total R as harvested after 24 h
incubation. The data represent the mean ± SD (n = 5 individual cultures). * p < 0.05, ** p < 0.01.
2.5. Cartilage-Specific CCN3 Overexpression Induced Degradative Changes in Articular Knee Joints and Rib
Chondrocytes In Vitro
To further verify the function of CCN3 in vivo, we generated CCN3-overexpressing mice under
the control of a 6 kb-Col2a1 promoter that included a cartilage-specific enhancer in the first intron of the
Col2a1 gene. The CCN3 gene was fused with the gene of green fluorescent protein (GFP), and IRES-LacZ
was also built in to trace the transgene expression. The activity of beta-galactosidase in cartilage
could be traced in up to 18-month-old knee joints (Figure 5A,B). Interestingly, Safranin-O staining of
two-month-old knee joints showed degenerative changes, such as thinning of articular cartilage layers
and surface roughening in transgenic mice (Figure 5C). Degenerative changes in articular cartilage were
more severe in seven-month-old mice (Figure 5D). In addition, immunohistochemical staining for the
aggrecan neoepitope in two-month-old knee joints showed positive staining in CCN3-overexpressing
articular cartilage only, indicating that overexpressed CCN3 in cartilage induced degenerative changes
in knee joints (Figure 5E).
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Figure 5. Degradative changes in knee joints and rib chondrocytes as a result of cartilage specific 
CCN3 overexpression in mice. (A) Whole mount LacZ staining of transgenic knee joints harboring a 
Col2a1 promoter-GFP-CCN3-LacZ construct (medial view). Beta-galactosidase activity was traceable 
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Figure 5. Degradative changes in knee joints and rib chondrocytes as a result of cartilage specific CCN3
overexpression in mice. (A) Whole mount LacZ staining of transgenic knee joints harboring a Col2a1
promoter-GFP-CCN3-LacZ construct (medial view). Beta-galactosidase activity was traceable up to
18 months after birth. (B) Histological analysis of (A) and counterstained with eosin. (C,D) Safranin-O
staining of two-month-old (C) and seven-month-old (D) Ccn3tg mice. (E) Immunohistochemical
staining of Aggrecan Neoepitope in two-month-old Ccn3tg mice knee articular cartilage. (wt -1st Ab)
Negative control without 1st antibody of wt sections. (F,G) Analysis of gene expression of extracellular
matrices and matrix metalloproteinases in chondrocyte RNA obtained from (F) rib cage chondrocytes
of embryonic 18.5-day-old and (G) ribcages of three-month-old of tg mice. (F) Increased expression of
p53, p21 and decreased expression Col2a1 mRNAs, were observed. (G) High expression levels of p21
and decreased expression levels of Col2a1, Acan, and Sox9 were observed. Furthermore, the expression
levels of inflammatory factors Il6, Il8, and Tnfα were increased. The p53 expression did not show
significant differences (data not shown). Scale bar: 200 µm.
Total RNA was obtained from the cultured primary chondrocytes of embryonic 18.5-day-old
ribcages and those from the ribcage and articular cartilage of three-month-old transgenic mice. Even
in 18.5-day-old Ccn3 transgenic rib chondrocytes, increased expression of p53, p21, Adamts5, and
Mmp13 mRNA, and decreased expression of type II collagen as observed. The Acan expression level
increased unexpectedly (Figure 5F, p < 0.01). In three- onth-old cn3 transgenic articular and ribcage
cartilage, p21, inflam atory factors of Il-6, Il-8, a f ere i ce ; i contrast, Col2a1, Aggrecan,
and Sox9 mRNA were downregulated (Figure 5G, p < 0. ). e er, 53 A did not show a
significant differ nce (dat not shown).
2.6. Elevation of CCN3, p53, and p21 mRNA Expression in u an rticular Cartilage ith ge
We also analyzed the expression level of CCN3 in hu a cartila e sa les tained after joint
surgery. Cartilage samples were obtained fro 14 ti t t rs ho ere relatively
healthy in those years, without osteoarthritic degenerati c . - analysis of primary
cultured chondrocytes from articular cartilage sho ed a str l ti bet een age and
CCN3, p53, and p21 expression levels (rs: 0.80308 f , . 018706 for p53/GAPDH,
0.8294835 for p21/GAPDH, p < 0.01, Figure 6A), whic is s milar to the result in mice (Figure 1). As note,
similar to ouse chondrocytes, human articular chondrocytes als showed dramatically decre sed
GAPDH expression (s e supplemental Figure S2). CCN3 mRNA level was also norm lized with amount
of RNA, and CCN3 mRNA still showed strong positive correlation betw en age (data ot shown).
Western blot analysis of cell lysates from 19- and 72-year-old primary articular chondrocytes showed
CCN3 bands with different molecular weights (Figure 6B, see also Section 3). Immunohistochemical
staining of CCN3 revealed strong positive staining in the superficial layer of femur articular cartilage
in 74- and 81-year-old patients (Figure 6C).
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3. Discussion
Osteoarthritic degenerative changes in articular cartilage are highly associated with chondrocyte
senescence caused by aging. In this study, e explored the role of CC 3 in aging in articular cartilage.
We observed significant induction of 3 in aging chondrocytes and in cells after oxidative stress-
induced senescence. Mouse chondrocytes from older a ults exhibited many changes in gene expression
that are typical of senescent cells, such as induction of p21 and p53, mediators of cell cycle arrest, Il-6
and Il-8, as SASP factors, and reductio of the extracellular matrix gene, Acan. Our dat support the
hypothesis that the phy iological stres es f aging induce the expression of c ll cycle arrest genes, ev n
in a hyporeplicative cell type such as chondrocytes.
A quantitative as ess ent of i ere by the observation that
aging is as ociated with changes i e ff l ctions, including
cellular metabolism; therefore, houseke ping genes are also not always stably expressed [19]. Recently,
transmemb e protein 199 (TMEM199) has been describe as a new c ndidate referenc gene to
normalize the RT-qPCR data of senescent cells [20]. In our study, a significant ncrease in the expression
of Ccn3 along with age was found by normalization, t only with Gapdh and RNA amount, but also
with Tmem199. Increased expression of CCN3 with age was also observ d in human articular cartil ge.
Changes in the expression of many marker genes in chondrocytes with age have been reported with
or without cartilage degeneration [21,22]. The reported changes, however, have to be taken with
care since many of the genes used as internal control show decreased expression along the age. For
example, in this report, Col2a1 did not show expression changes with age when standardized to Gapdh.
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Sox9 mRNA expression showed positive correlation with age when standardized to Gapdh, in contrast,
negative correlation was observed when normalized to total RNA.
Western blot analysis of human articular chondrocyte cell lysates showed CCN3 bands with
different molecular weights between young and aged chondrocytes; CCN3 in aging chondrocytes
showed a higher molecular weight, suggesting that CCN3 may undergo some modifications with age.
Whether this modification changed the CCN3 activity or stability needs to be further elucidated.
Cellular senescence is a complex phenotype characterized by two parameters: durable cell cycle
arrest induced by cellular stress; and the production of a set of pro-inflammatory molecules and matrix
metalloproteinases known as the senescence-associated secretory phenotype (SASP) [23–25]. Artificially
induced cellular senescence with oxidative stress by H2O2 in both human articular chondrocytes
and RCS cells induced CCN3 mRNA in a dose dependent manner. Genes of cell cycle arrest, p21
and p53 mRNA were also induced in both cells dose dependently. Induction of CCN3 and p53
proteins by H2O2 was also examined in RCS cells. Activation of SA-β gal was also detected in
H2O2 treated RCS cells demonstrating H2O2 induced cellular senescence in cultured chondrocytes
inducing CCN3 expression. Changing of mRNA expression of extracellular matrix was observed,
but not in a dose-dependent manner. Expression of COL2A1 and Acan mRNA rather enhances in
lower concentration of H2O2 in both primary chondrocytes and RCS cells, may indicating that mild
damage of chondrocytes by oxidative stress rather induces synthesis of cartilaginous matrices observed
in early stage of osteoarthritis [26]. Col10a1, Mmp13, and Adamts5 mRNA found in osteoarthritic
cartilage [27,28] were also strongly induced in H2O2 treated RCS cells, while a weaker response was
seen in primary chondrocytes. This may be the reason that immortalized cell line could not survive
when cell cycle was arrested, however, primary cultured cells go through maturation before death.
Not only elevated expression of CCN3 during aging and in induced senescent cells, but also
overexpression of CCN3 or addition of recombinant CCN3 protein to cultured chondrocytes in vitro
was found to induce cell cycle arrest by upregulating p53 and p21.
Furthermore, CCN3 overexpression in articular cartilage in vivo not only affected cell cycle
regulation but also induced characteristic features of senescence. In this report, severe degenerative
changes were observed in CCN3-overexpressing articular cartilage. For the gene expression analysis,
we isolated primary chondrocytes from rib cages of embryonic 18.5 days, and rib cage cartilage of
3 month old transgenic and wild type mice of the same littermates. Even in 3 month rib cage cartilage,
CCN3 induced Il-6, Il-8, and Tnfα which are considered as general SASP factors and also osteoarthritic
proinflammatory degenerative markers in articular cartilage. In addition, decreased expression of
Col2a1 and Acan mRNA was observed, which is consistent with a previous result [18]. However,
Mmp13 and Adamts5 mRNA were not upregulated in three-month old rib chondrocytes in contrast
to articular cartilage. p53 mRNA was not also elevated in three-month old rib RNA sample, this
may be due to the stably translated p53 protein level or p21 protein level. In E18.5-Ccn3 transgenic
chondrocytes, elevated expression of p53, p21, Adamts5, and Mmp13 mRNA was observed, but SASP
factors such as Il-6, Il-8, and Tnfα were not induced (data not shown), indicating that the induction of
those factors only occurs after birth.
A physiological interaction between CCN3 and p53 has not been reported so far. It is possible that
p53 regulates Ccn3 transcription or that CCN3 protein may upregulate another transcription factor(s)
which is induced along aging to upregulate p53. It is also possible that CCN3 protein may itself form
complexes that regulate cell cycle. Further studies will be necessary to clarify this problem.
Two different lines of CCN3-deficient mice have been reported: CCN3-deficient mice in which
exons 1 and 2 and part of exon 3 are replaced by the neomycin cassette showed enhanced neointimal
hyperplasia in response to injury. This is caused by repressing the inhibitory effects of CCN3 on vascular
smooth muscle cell proliferation, which is mediated by induction of p21 and p15 [29]. This report
is in line with our observation that CCN3 induced p21 and p53 expression in chondrocytes. In
our data, there was an increase in the expression level of p21 but not of p53 in three-month-old
CCN3-overexpressing cartilage. However, our finding that both treatment with recombinant CCN3
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and CCN3 overexpression significantly increased the p53 expression indicates that p53 regulation
by CCN3 also occurs in chondrocytes. The other CCN3-deficient mice caused by deletion of exon 3
showed skeletal abnormalities in some joints and heart defects [30]; 12-month-old male knee joints
showed some degenerative changes, but female joints did not [31]. Since these CCN3-deficient mice
were able to express the first 1 and 2 domains coded by exon 1 and 2, the phenotypes of these mice
must be interpreted with care. Whether those mice show prolonged life or anti-aging phenotype, or
not, needs to be analyzed.
Although the precise molecular mechanism of regulation of the cell cycle by CCN3 is still
unclear, there are several reports that CCN3 regulates NOTCH1 signaling [32]. The detailed signaling
mechanism of cell cycle control by CCN3 in adult articular cartilage should be investigated in
future studies.
The accumulation of senescent cells with aging contributes to age-related tissue dysfunction [33].
However, cellular senescence has also been considered as a protective system against tumorigenesis.
CCN3 has antiproliferative activities in several tumor cell lines [34–36]. In addition, CCN3 was
previously shown to be induced by glucose starvation [37]. Another report suggests that recombinant
CCN3 ameliorates 1L-1β induced metalloproteinases in cultured chondrocytes by the activation of
PI3K/AKT/mTOR pathway [38,39]. Taking these facts into consideration, it is assumed that the observed
CCN3 induction may be a protective response against multiple stimuli such as age-related oxidative
stress and nutrition shortages.
4. Conclusions
CCN3 can be a new marker of chondrocyte senescence, and CCN3 accelerates cellular senescence
via induction of p53 and p21.
5. Materials and Methods
5.1. Cell Cultures
Mouse primary articular chondrocytes were isolated from neonatal day 2 to 37-week-old articular
cartilage; primary ribcage chondrocytes were isolated from embryonic 18.5-day- and three-month-old
C57BL/6J mice, as previously described [40,41].
Human articular chondrocytes were obtained from patients with informed consent upon
orthopedic surgery in a traumatic clinical case approved by the Ethics Committee of Okayama
University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences (#K1506-018). Pieces
of knee articular cartilage were treated similarly to mouse articular cartilage, except for overnight
digestion with 2% collagenase. Rat chondrosarcoma-derived cells (RCS) were provided by Dr. Benoit
de Crombrugghe (The University of Texas MD Anderson Cancer Center, Houston, TX, USA) [42].
Cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal bovine
serum (FBS) at 37 ◦C with 5% CO2. Before the addition of recombinant mouse CCN3 (see Section 2.6),
RCS cells were cultured with DMEM containing 0.5% FBS for 24 h. All animal experiments were
conducted in accordance with the institutional rules under the approval from the Animal Care and Use
Committee of Okayama University, Okayama, Japan (OKU-2018903, OKU-2018023, OKU-2020328).
5.2. Isolation of Total RNA
Total RNA from cultured cells was extracted and purified using a RNeasy Mini Kit (Qiagen, Hilden,
Germany). For cartilage, tissues were homogenized with ISOGEN (Nippon Gene, Toyama, Japan), and
total RNA was further purified by a RNeasy Mini Kit, according to the manufacturer’s instructions.
5.3. Real-Time Polymerase Chain Reaction
Total RNAs were reverse-transcribed by a PrimeScript RT-reagent Kit (Takara Bio, Shiga, Japan).
Subsequent quantitative real-time PCR was performed using SYBR® Green Realtime PCR Master Mix
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(Toyobo Osaka, Japan) with a StepOnePlus™ (Applied Biosystems, Basel, Switzerland) Real-Time PCR
System. The primers used are listed in Tables 1–3. Expression of Gapdh was used to standardize total
amounts of cDNA; in some experiments, transmembrane protein 199 (Tmem199) or the amount of total
RNA was used for standardization.
Table 1. Primer sequences for mouse tissues.
Gene Forward Reverse
Ccn3 cagaccccaacaaccagact acttctctccgttgcggtaa
p16 gaactctttcggtcgtaccc agttcgaatctgcaccgtagt
p21 gaacatctcagggccgaaaa tgcgcttggagtgatagaaatc
p53 tcttatccgggtggaaggaaa ggcgaaaagtctgcctgtctt
Aggrecan gaggagagaactggagaag ggcgatagtggaatacaa
Col2a1 tggtggagcagcaagagcaa cagtggacagtagacggaggaaa
Col10a1 tgctgcctcaaataccctttct tggcgtatgggatgaagtattg
Sox9 atctgaagaaggagagcgag tcagaagtctccagagcttg
Il-6 ggagcccaccaagaacgata tcccaagaaggcaactggat
Il-8 aatttccaccggcaatgaag cccgaattggaaagggaaat
Mmp13 tcctcggagactggtaatgg tgatgaaacctggacaagca
Adamts-5 ggcatcattcatgtgacac gcatcgtaggtctgtcctg
Tnfα aggggattatggctcagggt tgagtccttgatggtggtgc
Tmem199 aaatggcgtcttccttgcttgc atcactgcccgcgtgtttctt
Gapdh * caatgaccccttcattgacc gacaagcttcccgttctcag
* Common to mice, RCS, and humans.
Table 2. Primer sequences for RCS.
Gene Forward Reverse
Ccn3 tgaagtctctgactccagcatt tggctttcagggatttcttg
p21 caaagtatgccgtcgtctgttc gaagtcaaagttccaccgttctc
p53 tccgactataccactatccactaca ggcacaaacacgaacctcaaa
Aggrecan agaatcaagtggagccgtgtt ggggatggctggatagttgg
Col2a1 ctcacgccttcccattgttg gttgttttggggttgagggttt
Col10a1 acctcccaccccattcca acccactattgctgctcactc
Mmp13 tgcggttcactttgaggaca tcttcttctatgaggcgggga
Adamts-5 tagaccctacagcaactccgt cctccacacactccacactt
Table 3. Primer sequences for humans.
Gene Forward Reverse
CCN3 ggagcgcgctataaaacctg tcccctctcgcttttaccaa
p21 tggggctgggagtagttgt gctggaaggtgtttggggt
p53 ggtcggtgggttggtagttt gtgtgggatggggtgagattt
5.4. Histology
Knee joints were fixed with 10% formaldehyde/PBS, demineralized with 0.5 M EDTA, dehydrated,
and embedded in paraffin. After the tissues were embedded in paraffin, serial frontal sections of 5 µm
thickness were cut through the knee joints.
5.5. Immunohistochemistry
Immunohistochemistry was done as reported previously [40,41]. Sections of knee joints were
treated with bovine testicular hyaluronidase (10 mg/mL) for 30 min at room temperature for epitope
retrieval, followed by 10% H2O2 in methanol for 10 min to inactivate endogenous peroxidase, and then
were immunostained with anti-CCN3 (provided by Dr. Takako Sasaki), or anti-aggrecan neo-epitope
(Novus Biologicals, Littleton, CO, USA) antibody. The signal was enhanced with Envision+ Dual
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Link System Peroxidase (Dako, Glostrup, Denmark) and developed with DAB (2 mg/mL). In some
experiments, the sections were counter-stained with methyl green.
5.6. Recombinant Mouse CCN3 and CCN3 Antibody
Protein coding region of mouse Ccn3 cDNA (NM_010930.5) including signal peptide was cloned
into the pCEP vector. The expression construct was transfected into 293 EBNA cells and serum-free
conditioned media were collected. The conditioned media were loaded onto DEAE cellulose (DE52)
equilibrated with 0.05 M Tris-HCl, pH 8.6 and eluted with a linear 0–0.5 M NaCl gradient in DEAE
buffer. Fractions containing CCN3 protein were concentrated by ammonium sulfate, and further
purified on Superose 12 HR 15/60 column eqilibrated with 0.2 M ammonium acetate. The CCN3
protein was dialyzed against PBS before addition to the cells.
CCN3 antiserum was obtained by immunizing rabbits with mrCCN3. For Western blot, 1:500
dilution, and for immunohistochemistry, 1:50 dilution were used. Specificity of antiserum was
monitored by comparison of the staining signal between CCN3 tg and wild type cartilage (supplemental
Figure S3).
5.7. Treatment with H2O2
After RCS cells reached confluence, the cells were exposed to 100–400 µM H2O2 for 2 h. The cells
were washed with DMEM and replenished with a fresh medium containing 10% FBS. Total RNAs were
collected after 24 h incubation, and cell lysates were collected after 24 and 48 h incubation.
5.8. Western Blots
Cultured cells were washed with PBS and harvested with 10 mM Tris–HCl (pH 8.0) in 150 mM
NaCl, 1% Triton X-100, and 0.1 mM phenylmethylsulphonyl fluoride. After the removal of precipitates,
5 µg of total protein were subjected to Western blot analysis. Primary antibodies against CCN3
(provided by Dr. Takako Sasaki, Oita University) and β-actin (Sigma, St Louis, MO, USA) were used.
5.9. Plasmids
For overexpression of CCN3 in RCS cells, mouse Ccn3 cDNA was ligated into a pEGFP-N1
vector (Clontech). For p21 reporter gene assay, a firefly luciferase reporter vector, pGL3-PG12S (kindly
provided by Dr. Inoue, Wakayama Medical University) containing 12× multiple p53-binding sites
upstream of the SV40 promoter, and the pGL3-Renilla vector, harboring renilla luciferase, were used.
5.10. p21 Promoter Reporter Gene Assay
RCS cells were seeded in 12-well plates at a density of 8.0 × 104 cells/well and incubated for 24 h.
The medium was changed, and pGL3-PG12S, pGL3-Renilla, and various amounts of pEGFP-CCN3 were
cotransfected into the RCS cells with PEI-MAX (kindly provided by Dr. Takarada, Okayama University)
according to the manufacturer’s instructions. Twenty-four hours after DNA transfection, luciferase
activities were measured using a Dual-Glo Luciferase Assay System (Promega). The transfection
efficiency was normalized to Renilla luciferase activity expressed from pGL3-Renilla. Mean values
were calculated from the results of three independent experiments.
5.11. Generation of Transgenic Mice
Ccn3 transgenic (Ccn3Tg) mice were generated and maintained in the C57BL/6J background,
in which murine Ccn3 fused with green fluorescent protein (GFP, Invitrogen, Carlsbad, CA, USA)
and IRES (internal ribosome entry site)-LacZ was driven under the control of the 6-kb Col2a1
promoter-enhancer. The sequences of PCR primers used for genotyping were 5′-GCATCGAGCTG
GGTAATAAGCGTTGGCAAT-3′ and 5′-GACACCAGACCAACTGGTAATGGTAGCGAC-3′, which
detects a fragment of LacZ.
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The knee joints and rib cartilage of sacrificed mice were isolated for RT-qPCR and histology.
All mice were housed in filter-top cages with paper-chip bedding under standard pathogen-free
conditions. The mice were fed a standard diet with tap water provided ad libitum.
5.12. X-Gal Staining
To trace transgene expression in articular cartilage, beta-galactosidase activity was monitored
from 1-, 2.5-, 7-, and 18-month-old transgenic knee joints using X-gal (5-bromo-4-chloro-3-indolyl-d-
galactopyranoside, Roche, Basel, Switzerland) as a substrate, as described before [41]. For staining of
knee joints, skin and muscle were removed before fixation. X-gal-stained knee joints were postfixed
overnight in 4% formaldehyde, dehydrated, and embedded in paraffin. Seven-micrometer-thick
sections were prepared by standard methods and counterstained with eosin.
For monitoring SA-β gal activity, the cells were fixed with 4% formaldehyde, and after washing
with PBS, the cells were stained with citric acid/sodium phosphate buffer (pH 6.4) containing 5 mM
potassium ferricyanate, 5 mM ferrocyanate, 150 mM NaCl, 2 mM MgCl2, 1 mg/mL X-gal for 2 h [43].
5.13. Safranin-O Staining
Safranin-O-fast green staining were used to analyze proteoglycan in articular cartilage.
5.14. Statistic Analysis
Data are presented as means ± standard deviation. The Spearman correlation coefficient was
used to explore possible associations between variables. Tukey’s multiple comparison tests was
used to determine the overall differences between groups. Unpaired Student’s t-tests were used for
comparisons between the control and subjects to determine significant differences. All calculations
were performed using statistical web software (http://www.gen-info.osaka-u.ac.jp/testdocs/tomocom/,
Osaka University, Japan). Values of p < 0.05 were considered statistically significant.
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